VARIAN – Juliana Denekamp Award
The Award The VARIAN-Juliana Denekamp Award was established in 2005 by ESTRO and honours the great and dearly missed European radiobiologist Prof. Dr. Juliana Denekamp. This award is sponsored by VARIAN Medical Systems, Switzerland.
In concordance with the outstanding scientific achievements of Prof. Juliana Denekamp and
her enthusiasm for promoting young talents, the award will be given to young scientists (junior radiobiologists or radiotherapists) who at a very early stage in their career have already demonstrated excellence and passion for biologically driven cancer research relevant to radiation oncology, and show promise that they will assume a scientific leadership role in this field in the future.
Born in 1943, Prof. Juliana Denekamp grew up in South Wales. She studied Zoology and Botany at the University of London and received her PhD at the Royal Postgraduate Medical School, Hammersmith Hospital, London, in 1968. Juliana Denekamp was a leading international scientist in radiation biology applied to radiotherapy, a field now called translational research in radiation oncology. Between 1988 and 1994 Juliana Denekamp was director of the Gray Laboratory, UK. Thereafter she was appointed as a Professor of Translational Research at the Umea University, Sweden, a position that she filled very actively both as researcher and teacher until her early death in June 2001.
The VARIAN-Juliana Denekamp Award is a prize of €2,500, which is awarded at the International Wolfsberg
Meeting on Molecular Radiation Biology/Oncology held in association with ESTRO in uneven years.
In 2011, the award will be presented during the 12th International Wolfsberg Meeting and the recipient will be chosen by the Scientific committee of the meeting.
Eligibility Criteria
Before applying for the award, candidates should be ESTRO members.
Candidates should not be older than 36 years of age. Exceptions will be made for female applicants who interrupted their research for pregnancy / maternity reasons for whom the upper age limit is fixed at 40 years.
Candidates should have published at least 2 – 3 first author, high quality publications on a particular topic in the field of biologically driven cancer research relevant to radiation oncology.
Submission Elements
Candidates should submit a curriculum vitae including a list of publications.
Candidates should submit the two or three articles published on one particular topic. If the articles were not published in English, an English summary (max. 2 pages) should also be submitted.
Submission
A paper copy of your submissions should be sent to:
Eralda Azizaj
ESTRO
Av. E. Mounierlaan 83
1200 Brussels, Belgium
An email copy of your submission should be sent to:
eralda.azizaj@estro.org
Closing Date: soon available
Previous Winners
2011
Ester Hammond (UK)
“Role of ATR and ATM as well as p53 for DNA repair signaling under hypoxic conditions”
Iris Eke (DE)
“Role of cell matrix interactions on cellular radiation response and its importance for radio- and chemo-resistance”
2009
Stéphane Supiot (FR)
“Sensitization of Prostate Cancer Cells to Radiation Therapy on the Basis of Interfering Approaches to
Radiation-Induced Signaling via p53 and ATM”
2007
Marianne Koritzinsky (NL)
“Regulation of protein folding during hypoxia”
Pierre Sonveaux (B)
“Therapeutic implications of tumor vasculature and its functional reactivity”
2005
M. Krause (UK) Carl Gustav Carus (DE)
“Decreased repopulation as well as increased reoxygenation contribute to the improvement in local
control after targeting of the EGFR by C223 during fractionated irradiation”
R Syljuasen, (DE)
“Targeting human checkpoint kinase Chk1 to modulate tumour radiosensitivity”